
News
Potentially life-saving treatment is safe to use for babies with neonatal sepsis, study reveals
Results from a clinical trial completed in Kenya have determined that a safe dose of the antibiotic, fosfomycin, can be used to treat babies with neonatal sepsis. This is a significant development, as there are very few antibiotics specifically licensed to treat multidrug-resistant infections in babies. The NeoFosfo trial investigated the pharmacokinetics (PK) and safety […]
Read More

News
Plasmodium falciparum parasite prevalence in East Africa: Updating data for malaria stratification
Read more here: Issue brief 30th June 2022
Read More

News
Examining the implementation of the Linda Mama free maternity program in Kenya
Maternal mortality is still unacceptably high in Kenya. A recently published policy brief examines the implementation of the Linda Mama free maternity program in Kenya. The process evaluation of the Linda Mama program reveals that there are barriers in access to maternal care, inefficiencies in the funding flow, claims process and reimbursement processes, and gaps […]
Read More

News
Rapid Review of Interventions to Save Newborn Lives (RISE)
Mainga Hamaluba, Head of Clinical Research at the KEMRI-Wellcome Trust Research Programme in Kenya, will develop a pragmatic adaptive trial platform to evaluate key interventions for improving child survival in East Africa in real-life routine practice conditions as a faster and lower-cost alternative to traditional randomized controlled trials. Dr. Hamaluba has led a wide-range of […]
Read More
News
SERVE-Kenya Study
Title: Social, Ethical and Regulatory implications of conducting a malaria Vaccine Efficacy trial in a human infection study in Kenya. Duration: 46 months Background Malaria remains an important public health problem in many LMICs, including Kenya – necessitating alternative prevention and control strategies. Malaria human infection studies (HIS) – trials that involve the deliberate infection […]
Read More

News
Rethinking Malaria in the Context of COVID–19
Please join KEMRI-Wellcome and Harvard University for a special 2-day webinar on focused on thematic topics stemming from the “Rethinking Malaria in the Context of COVID–19” global engagement—Malaria Governance, Integrated Service Delivery, Training & Capacity Building for Malaria on September 28–29, 2021 from 9AM–11:30AM EDT | 4PM–6:30PM EAT. In keeping with a longstanding academic tradition, and in partnership with a committed network of co-sponsors, we have assembled a diverse group […]
Read More

News
Royal Society Africa Prize winner 2021 – Prof. George Warimwe
Congratulations to Professor George Warimwe on being awarded the Royal Society Africa Prize winner 2021! Prof. Warimwe was awarded for his work on zoonoses vaccine development, capacity building in Africa, and his innovative research proposal. The Royal Society Africa Prize is to recognize research scientists based in Africa who are making an innovative contribution to […]
Read More

News
Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya.
Results from the first major genomic epidemiology of SARS-CoV-2 infections in Kenya were published today in the esteemed Nature Communications (DOI:10.1038/s41467-021-25137-x) peer-reviewed journal. The work carried by a team of scientist at the KEMRI-Wellcome Trust Research Programme and the Ministry of Health, examined cases during the early phase of the epidemic (March – July 2020). Out of […]
Read More

News
How the partnership between KPA and KEMRI-Wellcome birthed the Clinical Information Network
They say two things change the world: people with enough fortitude, conviction and ability; and ideas of how the world can be. The same can be said of the Clinical Information Network, which was established by a small group of people with an unwavering commitment to improving child health in the country. We spoke to […]
Read More

News
What it takes to reach ZERO MALARIA
By Keziah Njoki Malaria immunologist, Francis Ndungu, grew up in central Kenya where malaria is not prevalent but is now interested in understanding of how semi-immune individuals control malaria parasite growth and the associated inflammation (symptoms). He is also interested in the potential translation of that knowledge in the development of effective malaria vaccines. His […]
Read More